MFSD2B
gene geneOn this page
Also known as SLC59A2
Summary
MFSD2B (MFSD2 lysolipid transporter B, sphingolipid, HGNC:37207) is a protein-coding gene on chromosome 2p23.3, encoding Sphingosine-1-phosphate transporter MFSD2B (A6NFX1). Lipid transporter that specifically mediates export of sphingosine-1-phosphate in red blood cells and platelets.
Enables sphingolipid transporter activity. Involved in lipid transport. Is active in plasma membrane.
Source: NCBI Gene 388931 — RefSeq curated summary.
At a glance
- GWAS associations: 32
- Clinical variants (ClinVar): 64 total
- MANE Select transcript:
NM_001346880
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37207 |
| Approved symbol | MFSD2B |
| Name | MFSD2 lysolipid transporter B, sphingolipid |
| Location | 2p23.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SLC59A2 |
| Ensembl gene | ENSG00000205639 |
| Ensembl biotype | protein_coding |
| OMIM | 617845 |
| Entrez | 388931 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 3 protein_coding, 2 retained_intron, 1 nonsense_mediated_decay
ENST00000338315, ENST00000406420, ENST00000453731, ENST00000469562, ENST00000495018, ENST00000669179
RefSeq mRNA: 1 — MANE Select: NM_001346880
NM_001346880
CCDS: CCDS86824
Canonical transcript exons
ENST00000338315 — 14 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001183098 | 24023583 | 24023726 |
| ENSE00001183102 | 24023130 | 24023239 |
| ENSE00001536140 | 24021648 | 24021738 |
| ENSE00001536152 | 24017286 | 24017364 |
| ENSE00003471072 | 24016845 | 24016968 |
| ENSE00003475643 | 24022433 | 24022516 |
| ENSE00003514827 | 24013285 | 24013410 |
| ENSE00003593745 | 24017458 | 24017588 |
| ENSE00003595367 | 24024095 | 24024271 |
| ENSE00003615530 | 24021849 | 24021970 |
| ENSE00003634247 | 24022822 | 24022902 |
| ENSE00003641842 | 24016156 | 24016280 |
| ENSE00003692851 | 24025432 | 24026775 |
| ENSE00003901033 | 24010085 | 24010192 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 81.88.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 1.4601 / max 180.1310, expressed in 135 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 19166 | 1.2457 | 133 |
| 19167 | 0.2144 | 30 |
Top tissues by expression
136 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| blood | UBERON:0000178 | 81.88 | gold quality |
| monocyte | CL:0000576 | 79.18 | gold quality |
| bone marrow | UBERON:0002371 | 78.34 | gold quality |
| leukocyte | CL:0000738 | 78.29 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.46 | silver quality |
| bone marrow cell | CL:0002092 | 73.43 | gold quality |
| thymus | UBERON:0002370 | 69.18 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 68.52 | silver quality |
| stromal cell of endometrium | CL:0002255 | 68.42 | gold quality |
| placenta | UBERON:0001987 | 66.38 | gold quality |
| quadriceps femoris | UBERON:0001377 | 65.49 | gold quality |
| granulocyte | CL:0000094 | 65.33 | gold quality |
| cerebellar vermis | UBERON:0004720 | 64.61 | gold quality |
| sural nerve | UBERON:0015488 | 64.08 | gold quality |
| nucleus accumbens | UBERON:0001882 | 63.03 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 59.76 | gold quality |
| putamen | UBERON:0001874 | 59.11 | gold quality |
| ganglionic eminence | UBERON:0004023 | 58.76 | gold quality |
| caudate nucleus | UBERON:0001873 | 58.66 | gold quality |
| cortical plate | UBERON:0005343 | 58.30 | gold quality |
| right lung | UBERON:0002167 | 57.88 | gold quality |
| right coronary artery | UBERON:0001625 | 57.77 | gold quality |
| gastrocnemius | UBERON:0001388 | 57.69 | gold quality |
| muscle of leg | UBERON:0001383 | 57.61 | gold quality |
| muscle tissue | UBERON:0002385 | 57.60 | gold quality |
| colonic epithelium | UBERON:0000397 | 57.19 | silver quality |
| adrenal tissue | UBERON:0018303 | 56.67 | gold quality |
| tibial nerve | UBERON:0001323 | 55.78 | gold quality |
| myometrium | UBERON:0001296 | 55.26 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 55.15 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 8.35 |
| E-GEOD-124858 | no | 3.32 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 5)
- Results identify Mfsd2a (major facilitator superfamily domain-containing protein 2a) and an additional closely related protein Mfsd2b, and suggest that Mfsd2a plays a role in adaptive thermogenesis. (PMID:18694395)
- MFSD2B, CCL20 and STAT1, or STARD7 and ZNF512 genes may be risk or protect factors in prognosis of ADC; HTR2B, DPP4, and TGFBRAP1 genes may be risk factors in prognosis of SQC. (PMID:27301951)
- Using microarray analysis of erythroid cell lines overexpressing human and mouse MFSD2B study showed sphingosine 1-phosphate (S1P) transport activity. The properties of S1P release by MFSD2B were similar to those in erythrocytes. Moreover, knockout of MFSD2B in MEDEP-E14 cells decreased S1P export from the cells. These results strongly suggest that MFSD2B is a novel S1P transporter in erythroid cells. (PMID:29563527)
- Revealing concealed cardioprotection by platelet Mfsd2b-released S1P in human and murine myocardial infarction. (PMID:37100836)
- An erythrocyte-centric view on the MFSD2B sphingosine-1-phosphate transporter. (PMID:37390971)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mfsd2b | ENSDARG00000030263 |
| mus_musculus | Mfsd2b | ENSMUSG00000037336 |
| rattus_norvegicus | Mfsd2b | ENSRNOG00000023508 |
| caenorhabditis_elegans | WBGENE00017530 |
Paralogs (2): MFSD12 (ENSG00000161091), MFSD2A (ENSG00000168389)
Protein
Protein identifiers
Sphingosine-1-phosphate transporter MFSD2B — A6NFX1 (reviewed: A6NFX1)
Alternative names: Major facilitator superfamily domain-containing protein 2B
All UniProt accessions (4): A0A2I3JL00, A6NFX1, A0A590UK14, H7BZN4
UniProt curated annotations — full annotation on UniProt →
Function. Lipid transporter that specifically mediates export of sphingosine-1-phosphate in red blood cells and platelets. Sphingosine-1-phosphate is a signaling sphingolipid and its export from red blood cells into in the plasma is required for red blood cell morphology. Sphingosine-1-phosphate export from platelets is required for platelet aggregation and thrombus formation. Mediates the export of different sphingosine-1-phosphate (S1P) species, including S1P(d18:0) (sphinganine 1-phosphate), S1P (d18:1) (sphing-4-enine 1-phosphate) and S1P (d18:2) (sphinga-4E,14Z-dienine-1-phosphate). Release of sphingosine-1-phosphate is facilitated by a proton gradient. In contrast, cations, such as sodium, are not required to drive sphingosine-1-phosphate transport. In addition to export, also able to mediate S1P import. Does not transport lysophosphatidylcholine (LPC).
Subcellular location. Cell membrane.
Similarity. Belongs to the major facilitator superfamily.
RefSeq proteins (1): NP_001333809* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR036259 | MFS_trans_sf | Homologous_superfamily |
| IPR039672 | MFS_2 | Family |
Pfam: PF13347
Catalyzed reactions (Rhea), 3 shown:
- sphing-4-enine 1-phosphate(in) = sphing-4-enine 1-phosphate(out) (RHEA:38667)
- sphinganine 1-phosphate(in) = sphinganine 1-phosphate(out) (RHEA:38671)
- sphinga-4E,14Z-dienine-1-phosphate(in) = sphinga-4E,14Z-dienine-1-phosphate(out) (RHEA:70207)
UniProt features (18 total): transmembrane region 10, mutagenesis site 3, region of interest 2, compositionally biased region 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NFX1-F1 | 80.82 | 0.46 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Mutagenesis-validated functional residues (3):
| Position | Phenotype |
|---|---|
| 95 | abolishes export of sphingosine-1-phosphate. |
| 157 | abolishes export of sphingosine-1-phosphate. |
| 423 | does not affect export of sphingosine-1-phosphate. |
Function
Pathways and Gene Ontology
Reactome pathways
4 pathways
| ID | Pathway |
|---|---|
| R-HSA-1660661 | Sphingolipid de novo biosynthesis |
| R-HSA-1430728 | Metabolism |
| R-HSA-428157 | Sphingolipid metabolism |
| R-HSA-556833 | Metabolism of lipids |
MSigDB gene sets: 86 (showing top):
GOBP_REGULATION_OF_CELL_ACTIVATION, GOBP_CARBOHYDRATE_TRANSPORT, GOBP_SPHINGOLIPID_MEDIATED_SIGNALING_PATHWAY, GOBP_PLATELET_ACTIVATION, GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION, GOBP_WOUND_HEALING, GOBP_CELL_CELL_ADHESION, GOBP_REGULATION_OF_PLATELET_AGGREGATION, GOBP_SPHINGOLIPID_METABOLIC_PROCESS, GOBP_LIPID_METABOLIC_PROCESS, GOBP_LIPID_BIOSYNTHETIC_PROCESS, GOBP_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION, GOBP_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION, REACTOME_SPHINGOLIPID_METABOLISM, GOBP_HOMOTYPIC_CELL_CELL_ADHESION
GO Biological Process (6): sphingosine-1-phosphate receptor signaling pathway (GO:0003376), lipid transport (GO:0006869), carbohydrate transport (GO:0008643), sphingolipid biosynthetic process (GO:0030148), transmembrane transport (GO:0055085), positive regulation of platelet aggregation (GO:1901731)
GO Molecular Function (2): symporter activity (GO:0015293), sphingolipid intramembrane carrier activity (GO:0046624)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Sphingolipid metabolism | 1 |
| Metabolism of lipids | 1 |
| Metabolism | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transport | 3 |
| G protein-coupled receptor signaling pathway | 1 |
| sphingolipid mediated signaling pathway | 1 |
| lipid localization | 1 |
| sphingolipid metabolic process | 1 |
| lipid biosynthetic process | 1 |
| cellular process | 1 |
| positive regulation of homotypic cell-cell adhesion | 1 |
| platelet aggregation | 1 |
| regulation of platelet aggregation | 1 |
| secondary active transmembrane transporter activity | 1 |
| intramembrane lipid carrier activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
594 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MFSD2B | SPNS2 | Q8IVW8 | 990 |
| MFSD2B | SPNS1 | Q9H2V7 | 857 |
| MFSD2B | SPHK1 | Q9NYA1 | 718 |
| MFSD2B | SPHK2 | Q9NRA0 | 696 |
| MFSD2B | S1PR2 | O95136 | 691 |
| MFSD2B | S1PR3 | Q99500 | 658 |
| MFSD2B | S1PR5 | Q9H228 | 603 |
| MFSD2B | S1PR4 | O95977 | 582 |
| MFSD2B | APOM | O95445 | 571 |
| MFSD2B | SLC33A2 | Q96ES6 | 560 |
| MFSD2B | SGPL1 | O95470 | 541 |
| MFSD2B | SPNS3 | Q6ZMD2 | 541 |
| MFSD2B | SLC67A2 | Q8NBP5 | 540 |
| MFSD2B | MFSD11 | O43934 | 521 |
| MFSD2B | SLC75A1 | Q14728 | 513 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MFSD2B | USP33 | psi-mi:“MI:0915”(physical association) | 0.400 |
| HIF1A | MFSD2B | psi-mi:“MI:0915”(physical association) | 0.400 |
| MFSD2B | TNFRSF10B | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (15): MFSD2B (Affinity Capture-RNA), ARHGEF1 (Affinity Capture-MS), ATP11C (Affinity Capture-MS), ATP6V0A1 (Affinity Capture-MS), ATP6V0A2 (Affinity Capture-MS), CR2 (Affinity Capture-MS), ENPP1 (Affinity Capture-MS), ERLIN2 (Affinity Capture-MS), KDM5C (Affinity Capture-MS), MARCH5 (Affinity Capture-MS), MARVELD2 (Affinity Capture-MS), PTPRJ (Affinity Capture-MS), RETSAT (Affinity Capture-MS), TMEM33 (Affinity Capture-MS), TNFRSF10B (Affinity Capture-MS)
ESM2 similar proteins: A0A3Q2HW92, A6NDV4, A6NFX1, A6QLK4, B1AWJ5, F1NCD6, F1NJ67, F1PZV2, O35308, O35595, O70461, O95907, Q08DX7, Q0IHM1, Q0P5C0, Q0P5M9, Q13286, Q14728, Q29611, Q2YDU8, Q3T9M1, Q3U481, Q501I9, Q5R8G5, Q5R9A1, Q5U419, Q60HH0, Q61124, Q66H95, Q6NUT3, Q6UXD7, Q6ZMD2, Q7RTT9, Q8BFQ6, Q8CE47, Q8NA29, Q8R0G7, Q8R139, Q8TB61, Q8VCW4
Diamond homologs: A4IH46, A6NFX1, F1NCD6, Q0IHM1, Q3T9M1, Q5U3U7, Q6DEJ6, Q8NA29, Q9DA75
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
64 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 57 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3730 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:24010192:GGTG:G | donor_loss | 1.0000 |
| 2:24010193:G:GA | donor_loss | 1.0000 |
| 2:24010194:T:G | donor_loss | 1.0000 |
| 2:24017365:G:GG | donor_gain | 1.0000 |
| 2:24017589:G:GG | donor_gain | 1.0000 |
| 2:24022817:CACA:C | acceptor_loss | 1.0000 |
| 2:24022820:AGGT:A | acceptor_loss | 1.0000 |
| 2:24022901:TT:T | donor_gain | 1.0000 |
| 2:24022901:TTGTG:T | donor_loss | 1.0000 |
| 2:24022903:G:GG | donor_gain | 1.0000 |
| 2:24022903:G:T | donor_loss | 1.0000 |
| 2:24022907:G:GG | donor_gain | 1.0000 |
| 2:24023578:CGCA:C | acceptor_loss | 1.0000 |
| 2:24023579:GCA:G | acceptor_loss | 1.0000 |
| 2:24023580:CAGG:C | acceptor_loss | 1.0000 |
| 2:24023581:AGGT:A | acceptor_loss | 1.0000 |
| 2:24023582:GGTCC:G | acceptor_gain | 1.0000 |
| 2:24023724:GGA:G | donor_gain | 1.0000 |
| 2:24023725:GA:G | donor_gain | 1.0000 |
| 2:24023725:GAG:G | donor_gain | 1.0000 |
| 2:24023727:G:GG | donor_gain | 1.0000 |
| 2:24023738:GGT:G | donor_gain | 1.0000 |
| 2:24024090:TCCA:T | acceptor_loss | 1.0000 |
| 2:24024092:CAGG:C | acceptor_loss | 1.0000 |
| 2:24024093:A:AG | acceptor_gain | 1.0000 |
| 2:24024093:A:C | acceptor_loss | 1.0000 |
| 2:24024093:AG:A | acceptor_gain | 1.0000 |
| 2:24024094:G:GA | acceptor_gain | 1.0000 |
| 2:24024094:GG:G | acceptor_gain | 1.0000 |
| 2:24024094:GGTT:G | acceptor_gain | 1.0000 |
AlphaMissense
3203 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:24017458:G:C | R184P | 0.993 |
| 2:24013390:T:C | F68L | 0.991 |
| 2:24013392:C:A | F68L | 0.991 |
| 2:24013392:C:G | F68L | 0.991 |
| 2:24023211:A:C | S381R | 0.991 |
| 2:24023213:C:A | S381R | 0.991 |
| 2:24023213:C:G | S381R | 0.991 |
| 2:24022837:A:C | S332R | 0.988 |
| 2:24022839:C:A | S332R | 0.988 |
| 2:24022839:C:G | S332R | 0.988 |
| 2:24023206:G:A | G379D | 0.986 |
| 2:24016891:T:A | W132R | 0.985 |
| 2:24016891:T:C | W132R | 0.985 |
| 2:24022849:T:A | W336R | 0.985 |
| 2:24022849:T:C | W336R | 0.985 |
| 2:24023205:G:C | G379R | 0.983 |
| 2:24022457:T:C | F307L | 0.982 |
| 2:24022459:C:A | F307L | 0.982 |
| 2:24022459:C:G | F307L | 0.982 |
| 2:24013331:G:A | G48D | 0.981 |
| 2:24013330:G:C | G48R | 0.980 |
| 2:24013363:A:C | S59R | 0.980 |
| 2:24013365:C:A | S59R | 0.980 |
| 2:24013365:C:G | S59R | 0.980 |
| 2:24021963:C:A | A296D | 0.980 |
| 2:24017490:G:A | G195R | 0.978 |
| 2:24017490:G:C | G195R | 0.978 |
| 2:24024195:G:A | G472R | 0.978 |
| 2:24024195:G:C | G472R | 0.978 |
| 2:24013391:T:C | F68S | 0.977 |
dbSNP variants (sampled 300 via entrez): RS1000012917 (2:24025943 C>A,T), RS1000066663 (2:24020894 T>A), RS1000234531 (2:24018215 G>A), RS1000287005 (2:24018000 A>G), RS1000442489 (2:24024011 G>A,C,T), RS1000567147 (2:24019685 T>C,G), RS1000741968 (2:24016731 C>T), RS1001198494 (2:24010243 A>G), RS1001239095 (2:24016936 A>T), RS1001394910 (2:24022964 T>C), RS1001605012 (2:24016739 A>G), RS1001780971 (2:24022716 G>C), RS1002215889 (2:24010022 G>A,C,T), RS1002287741 (2:24018062 T>G), RS1002682295 (2:24020968 C>T)
Disease associations
OMIM: gene MIM:617845 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
32 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004609_136 | Monocyte percentage of white cells | 4.000000e-21 |
| GCST004611_7 | High light scatter reticulocyte count | 4.000000e-26 |
| GCST004612_164 | High light scatter reticulocyte percentage of red cells | 1.000000e-29 |
| GCST004619_48 | Reticulocyte fraction of red cells | 9.000000e-20 |
| GCST004622_148 | Reticulocyte count | 2.000000e-15 |
| GCST004627_136 | Lymphocyte count | 9.000000e-40 |
| GCST004628_142 | Immature fraction of reticulocytes | 5.000000e-27 |
| GCST004632_126 | Lymphocyte percentage of white cells | 7.000000e-13 |
| GCST006268_492 | Reaction time | 5.000000e-08 |
| GCST008163_219 | Height | 3.000000e-07 |
| GCST012126_2 | hemolysis of donated blood (osmotic) | 5.000000e-08 |
| GCST012135_2 | hemolysis of donated blood (osmotic) | 1.000000e-13 |
| GCST90002385_118 | High light scatter reticulocyte count | 9.000000e-31 |
| GCST90002386_236 | High light scatter reticulocyte percentage of red cells | 8.000000e-25 |
| GCST90002386_237 | High light scatter reticulocyte percentage of red cells | 4.000000e-16 |
| GCST90002387_251 | Immature fraction of reticulocytes | 2.000000e-11 |
| GCST90002387_252 | Immature fraction of reticulocytes | 3.000000e-27 |
| GCST90002388_64 | Lymphocyte count | 1.000000e-60 |
| GCST90002388_65 | Lymphocyte count | 2.000000e-10 |
| GCST90002389_103 | Lymphocyte percentage of white cells | 7.000000e-16 |
| GCST90002397_765 | Mean spheric corpuscular volume | 2.000000e-59 |
| GCST90002397_791 | Mean spheric corpuscular volume | 4.000000e-09 |
| GCST90002399_158 | Neutrophil percentage of white cells | 3.000000e-17 |
| GCST90002400_557 | Plateletcrit | 2.000000e-11 |
| GCST90002400_558 | Plateletcrit | 2.000000e-09 |
| GCST90002403_75 | Red blood cell count | 3.000000e-41 |
| GCST90002405_112 | Reticulocyte count | 3.000000e-16 |
| GCST90002405_113 | Reticulocyte count | 1.000000e-10 |
| GCST90002406_7 | Reticulocyte fraction of red cells | 6.000000e-19 |
| GCST90002406_8 | Reticulocyte fraction of red cells | 7.000000e-12 |
EFO canonical traits (10, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007989 | monocyte percentage of leukocytes |
| EFO:0007986 | reticulocyte count |
| EFO:0004587 | lymphocyte count |
| EFO:0007993 | lymphocyte percentage of leukocytes |
| EFO:0008393 | reaction time measurement |
| EFO:0009473 | hemolysis |
| EFO:0007990 | neutrophil percentage of leukocytes |
| EFO:0007985 | platelet crit |
| EFO:0004305 | erythrocyte count |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — SLC59 Sodium-dependent lysophosphatidylcholine symporter family
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases methylation | 1 |
| abrine | increases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Smoke | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D4GL | HCT116-MFSD2B-KO-c17 | Cancer cell line | Male |
| CVCL_D4GM | HCT116-MFSD2B-KO-c21 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.